Key result
WATCHMAN implantation in octogenarians is linked to ~7-point higher physical QoL scores vs. population norms.
Why the study?
The impact of WATCHMAN device implantation on long-term quality of life in octogenarians and nonagenarians with nonvalvular atrial fibrillation remained unknown.
Does WATCHMAN device implantation improve long-term quality of life in octogenarians and nonagenarians with nonvalvular atrial fibrillation?
Cohort (n=151)
No
Does WATCHMAN device implantation improve long-term quality of life in octogenarians and nonagenarians with nonvalvular atrial fibrillation?
Octogenarians and nonagenarians undergoing WATCHMAN device implantation experience favorable long-term quality of life, acceptable bleeding risk, and a low incidence of procedure-related complications comparable to patients under 80 years of age.
Answers are grounded in this paper and cite their sources.
Supports QoL gains in octogenarians; extends observational data but leaves open need for RCTs.
OBJECTIVES: To assess the impact of WATCHMAN™ on quality of life (QoL) in octogenarians and nonagenarians. BACKGROUND: QoL after WATCHMAN™ device in the elderly remains unknown. METHODS: This is a prospective and retrospective cohort study of patients that underwent WATCHMAN™ implantation in a tertiary cardiovascular center from April 1, 2015 to September 27, 2017. The primary outcome was a prospective assessment of QoL via the SF-12v2 Health Survey (SF-12v2) in those aged ≥80 and ≥90 years. Secondary outcomes include major bleeding, stroke, vascular complications, pericardial effusion, device related thrombus (DRT), prolonged length of stay (LOS), acute kidney injury (AKI), and recurrent hospitalizations. Octogenarians 65/81(80%) and nonagenarians 16/81(20%) comprised 81/151(54%) of patients (mean age 86 ± 4.3 years) from which 36/65 (55%) octogenarians and 10/16 (63%) nonagenarians completed SF-12v2 evaluation at 22 ± 10 and 30 ± 10-months. Octogenarians demonstrated enhanced physical component scores (PCS), and nonagenarians equal PCS versus the age-adjusted norm (45.43 ± 9.84 versus 38.68 ± 11.04, P = 0.0003, and 41.26 ± 12.36 versus 38.68 ± 11.04, P = 0.6463, respectively). The mental component scores (MCS) of octogenarians and nonagenarians remained comparable (51.80 ± 9.56 and 48.97 ± 9.92 versus 50.06 ± 10.94, respectively, P = 0.4659). No stroke, vascular complications, pericardial effusions, or readmissions related to WATCHMAN™ occurred. No difference among patients <80, ≥80, and ≥90 years was found in major bleeding events, DRT, prolonged LOS, or AKI (P = 0.0569, 0.116, 0.498, and 0.795, respectively). CONCLUSIONS: Octogenarians and nonagenarians experience favorable long-term QoL after WATCHMAN™, with acceptable bleeding risk and low incidence of procedure-related complications.
No takes yet. Share an insight, caveat, or question.
Tuarez et al. (2018) conducted a cohort in Nonvalvular atrial fibrillation (n=151). WATCHMAN device implantation vs. Age-adjusted norm (for QoL) and patients <80 years (for clinical outcomes) was evaluated on Quality of life (QoL) via the SF-12v2 Health Survey (physical component scores [PCS] and mental component scores [MCS]) (p=0.0003). WATCHMAN implantation in octogenarians resulted in enhanced SF-12v2 physical component scores compared to the age-adjusted norm and comparable scores in nonagenarians.
Synapse has enriched 10 related papers. Consider them for comparative context: